Agenus acquires Swiss biopharmaceutical firm 4-Antibody - 0 views
-
Alex Parker on 14 Feb 14US-based developer of new immunotherapeutics, including a portfolio of checkpoint modulators, anti-cancer vaccines and adjuvants, Agenus has completed the acquisition of Switzerland-based biopharmaceutical firm 4-Antibody.